NeuroOne Medical Technologies Corporation
NMTC
$0.6043
$0.04237.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.47% | 153.37% | -6.87% | 20.22% | 18.95% |
| Total Depreciation and Amortization | 7.72% | 10.90% | 2.56% | 10.70% | 38.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -129.15% | -67.59% | 178.38% | 14.84% | 58.00% |
| Change in Net Operating Assets | 871.81% | -125.95% | -87.65% | -115.07% | 173.38% |
| Cash from Operations | 97.42% | 105.46% | 8.13% | 19.72% | 38.75% |
| Capital Expenditure | 89.81% | 34.23% | 35.94% | 89.38% | 82.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 89.81% | 34.23% | 26.35% | -101.72% | -101.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -80.23% | -- | -86.14% | 3.63% | 125.60% |
| Repurchase of Common Stock | -847.79% | 16.91% | -13.95% | -282.79% | 88.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 49.71% | -1,221.22% | 305.15% | -48.25% | 26.79% |
| Cash from Financing | -87.49% | -142.27% | -51.00% | -0.02% | 196.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 175.48% | 87.67% | -107.14% | -57.07% | 76.88% |